Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is

Florie Borel1, Ruiqi Han, Allerdien Visser

  • 1Department of Research & Development, Amsterdam Molecular Therapeutics, Amsterdam, The Netherlands.

Hepatology (Baltimore, Md.)
|September 21, 2011
PubMed
Abstract

Insights

Adenosine triphosphate (ATP)-binding cassette (ABC) transporters are upregulated in hepatocellular carcinoma (HCC) before treatment. MicroRNAs (miRNAs) may regulate these transporters, offering potential for new HCC therapies to overcome drug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Hepatocellular carcinoma (HCC) treatment failure is often caused by multidrug resistance mediated by Adenosine triphosphate (ATP)-binding cassette (ABC) transporters.
  • Understanding the regulation of ABC transporters in HCC is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the expression of ABC transporters in HCC patient samples.
  • To explore the role of microRNAs (miRNAs) in regulating ABC transporter expression in HCC.

Main Methods:

  • Analysis of 15 ABC transporters in 19 paired HCC and adjacent healthy liver samples.
  • miRNA profiling in HCC versus healthy liver tissues.
  • Bioinformatic prediction and in vitro luciferase reporter assays to validate miRNA-ABC gene interactions.

Main Results:

  • Twelve ABC transporters were found to be upregulated in HCC tissues compared to healthy liver.
  • Dysregulation of 90 miRNAs was observed in HCC, with 11 upregulated and 79 downregulated.
  • Thirteen miRNAs were confirmed to target and mediate expression changes in five specific ABC genes (ABCA1, ABCC1, ABCC5, ABCC10, ABCE1).

Conclusions:

  • ABC transporter upregulation in HCC occurs early, even before chemotherapy, and is linked to miRNA downregulation.
  • A subset of miRNAs directly regulates key ABC genes in HCC.
  • miRNA-based therapeutic strategies hold promise for overcoming multidrug resistance in HCC.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...